Rheumatology and psychiatry: allies in times of COVID-19
- ,
- Jeff Huarcaya-Victoria,
- Graciela S. Alarcón,
- ,
- Universidad Científica del Sur,
- Universidad Nacional Mayor de San Marcos,
- Hospital Guillermo Almenara Irigoyen,
- Universidad Peruana Cayetano Heredia,
- University of Alabama at Birmingham School of Medicine
Research Output:
Contribution to journal
Review article
Peer-review
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Review article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 3363-3367 (5 pages)Journal (Volume, Issue Number)
Clinical Rheumatology (Volume 40, Issue 8)Publication milestones
- Published - 08/2021
Publication status
Published - 08/2021
ISSN
0770-3198Publication IDs
- Scopus: 85106724305
- PubMed: 34050441
Abstract
The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients’ quality of life can be substantially improved.
Funding Details
The authors thank Renato D. Alarcón, MD, MPH, Professor Emeritus of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN; and Honorio Delgado Chair, Universidad Peruana Cayetano Heredia, Lima, Peru, for providing expert assistance in the review of the manuscript.
FundersFunding numbers
Mayo Clinic
-UPCH
-Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Citations
6
Captures
38
Sustainable Development Goals
SDG 3 Good Health and Well